Notably, albeit p-4E has been shown as a key factor to enhance oncogenic translation function by MNK1/2, cellular responsiveness of p-4E to MNK kinase inhibitors decoupled from the growth-inhibitory effect of these compounds in STS. The gene discussed is MKNK1; the disease is telomere syndrome.